OMNIPOD INSULIN PUMP
Report
- Report Number
- 3004464228-2013-00222
- Event Type
- Injury
- Date Received
- March 15, 2013
- Date of Event
- January 1, 2013
- Report Date
- February 13, 2013
- Manufacturer
- INSULET CORPORATION
- Product Code
- LZG
- PMA / PMN Number
- K042792
- Adverse Event
- Yes
- Report Source
- Manufacturer report
- Reporter Occupation
- OTHER
Narratives
THE PRODUCT WAS RETURNED FOR EVAL. WE ARE UNABLE TO DETERMINE IF ANY MALFUNCTION COULD HAVE CONTRIBUTED TO THE REPORTED DIABETIC KETOACIDOSIS, HEART ATTACK, AND HOSPITALIZATION. NO LOT QUALIFICATION RECORDS WERE REVIEWED, AS NO PRODUCT LOT NUMBER WAS PROVIDED. THE OMNIPOD USER GUIDE WARNS, "TEST RESULTS GREATER THAN 250 MG/DL MEAN HIGH BLOOD GLUCOSE (HYPERGLYCEMIA). IF YOU GET RESULTS ABOVE 250 MG/DL, BUT DO NOT HAVE SYMPTOMS OF HYPERGLYCEMIA, REPEAT THE TEST. IF YOU HAVE SYMPTOMS OR CONTINUE TO GET RESULTS THAT FALL ABOVE 250 MG/DL, FOLLOW THE TREATMENT ADVICE OF YOUR HEALTHCARE PROVIDER" AND "IF LEFT UNTREATED, DKA CAN CAUSE BREATHING DIFFICULTIES, SHOCK, COMA, AND EVENTUALLY DEATH." IT ADVISES, "THE EASIEST AND MOST RELIABLE WAY TO AVOID DKA IS BY CHECKING YOUR BLOOD GLUCOSE AT LEAST 4-6 TIMES A DAY. ROUTINE CHECKS ALLOW YOU TO IDENTIFY AND TREAT HIGH BLOOD GLUCOSE BEFORE DKA DEVELOPS" AND "IF YOUR BLOOD GLUCOSE IS 250 MG/DL OR ABOVE, CHECK FOR KETONES. IF KETONES ARE PRESENT, FOLLOW YOUR HEALTHCARE PROVIDER'S GUIDELINES. IF KETONES ARE NOT PRESENT, TAKE A CORRECTION BOLUS AS PRESCRIBED BY YOUR HEALTHCARE PROVIDER. CHECK BLOOD GLUCOSE AGAIN AFTER 2 HOURS. IF BLOOD GLUCOSE LEVELS HAVE NOT DECREASED, TAKE A SECOND BOLUS BY INJECTION, USING A STERILE SYRINGE. IF YOU FEEL NAUSEATED AT ANY POINT, CHECK FOR KETONES AND CALL YOUR HEALTHCARE PROVIDER IMMEDIATELY."
THE CUSTOMER REPORTED THAT SHE WAS HOSPITALIZED FOR 4 DAYS WITH DIABETIC KETOACIDOSIS. HER BLOOD GLUCOSE WAS 399 MG/DL, AND SHE SAID THAT SHE WAS VOMITING AND TAKEN TO THE HOSPITAL BY AMBULANCE. SHE SAID THAT HER PHYSICIAN TOLD HER SHE MAY HAVE HAD A MILD HEART ATTACK, BUT IT IS NOT CLEAR WHEN THE HEART ATTACK OCCURRED. THE CUSTOMER BELIEVES THAT THE POD WAS INVOLVED. SHE REPORTED THAT SHE COULD NOT GET HER BLOOD GLUCOSE TO DECREASE WITH THE POD SHE WAS WEARING, AND THAT IT WAS ON HER BACK, POSSIBLY TOO CLOSE TO HER SPINE. WHEN SHE CHANGED THE POD, SHE SAID THAT HER BLOOD GLUCOSE LEVEL STARTED TO DECREASE.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 110703 | OMNIPOD INSULIN PUMP | PUMP, INFUSION, INSULIN | LZG | INSULET CORPORATION | 11200 |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | 68 YR | Hospitalization |